BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Drepper MD, Spahr L, Frossard JL. Clopidogrel and proton pump inhibitors - where do we stand in 2012? World J Gastroenterol 2012; 18(18): 2161-2171 [PMID: 22611308 DOI: 10.3748/wjg.v18.i18.2161]
URL: https://www.wjgnet.com/1007-9327/full/v18/i18/2161.htm
Number Citing Articles
1
Jingtao Chen, Patrick Brady. Gastroesophageal Reflux DiseaseGastroenterology Nursing 2019; 42(1): 20 doi: 10.1097/SGA.0000000000000359
2
Ana María Pello Lázaro, Carmen Cristóbal, Juan Antonio Franco-Peláez, Nieves Tarín, Álvaro Aceña, Rocío Carda, Ana Huelmos, María Luisa Martín-Mariscal, Jesús Fuentes-Antras, Juan Martínez-Millá, Joaquín Alonso, Óscar Lorenzo, Jesús Egido, Lorenzo López-Bescós, José Tuñón, Raffaele Bugiardini. Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery DiseasePLOS ONE 2017; 12(1): e0169826 doi: 10.1371/journal.pone.0169826
3
Md.Mohaimenul Islam, Tahmina N. Poly, Bruno A. Walther, Navneet K. Dubey, Dina N. Anggraini Ningrum, Syed-Abdul Shabbir, Yu-Chuan (Jack) Li. Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology 2018; 30(12): 1395 doi: 10.1097/MEG.0000000000001198
4
Yusmiati Yusmiati, Dewi Muliaty. The Pharmacogenetics of Cytochrome P450 2C19 Enzymes - Effects on Clopidogrel and Proton Pump InhibitorsThe Indonesian Biomedical Journal 2014; 6(1): 33 doi: 10.18585/inabj.v6i1.41
5
Nikhil Kapil, Yvonne H. Datta, Naila Alakbarova, Eric Bershad, Magdy Selim, David S. Liebeskind, Ornina Bachour, Gundu H. R. Rao, Afshin A. Divani. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic StrokeClinical and Applied Thrombosis/Hemostasis 2017; 23(4): 301 doi: 10.1177/1076029616660762
6
Ingvild Aune Søraas, Hanne Baust Staurset, Lars Slørdal, Olav Spigset. Legemiddelinteraksjoner hos pasienter i sykehjemTidsskrift for Den norske legeforening 2014; 134(10): 1041 doi: 10.4045/tidsskr.13.1550
7
Walter N. Kernan, Bruce Ovbiagele, Henry R. Black, Dawn M. Bravata, Marc I. Chimowitz, Michael D. Ezekowitz, Margaret C. Fang, Marc Fisher, Karen L. Furie, Donald V. Heck, S. Claiborne (Clay) Johnston, Scott E. Kasner, Steven J. Kittner, Pamela H. Mitchell, Michael W. Rich, DeJuran Richardson, Lee H. Schwamm, John A. Wilson. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic AttackStroke 2014; 45(7): 2160 doi: 10.1161/STR.0000000000000024
8
Michael A. Serbin, Gregory F. Guzauskas, David L. Veenstra. Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysisJournal of Managed Care & Specialty Pharmacy 2016; 22(8): 939 doi: 10.18553/jmcp.2016.22.8.939
9
José María Remes-Troche, Sergio Sobrino-Cossío, Julio César Soto-Pérez, Oscar Teramoto-Matsubara, Miguel Morales-Arámbula, Antonio Orozco-Gamiz, José Luis Tamayo de la Cuesta, Gualberto Mateos. Efficacy, Safety, and Tolerability of Pantoprazole Magnesium in the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease (GERD): A Prospective, Multicenter, Post-Marketing Observational StudyClinical Drug Investigation 2014; 34(2): 83 doi: 10.1007/s40261-013-0135-4
10
Catherine Marcucci, Neil B. Sandson. A Case Approach to Perioperative Drug-Drug Interactions2015; : 685 doi: 10.1007/978-1-4614-7495-1_152
11
Omer Allela. Explore Adverse Drug Reactions (ADRs) reporting by clinical and community pharmacists in Duhok, Kurdistan region- Iraq: hampered and perspectivePharmacia 2022; 69(4): 1057 doi: 10.3897/pharmacia.69.e95691
12
Tomáš Bolek, Matej Samoš, Radoslava Šimonová, František Kovář, Marián Fedor, Peter Galajda, Ján Staško, Peter Kubisz, Marián Mokáň. Does Pantoprazole Affect the On-Treatment Platelet Reactivity in Patients With Acute STEMI Treated With ADP Receptor Blockers?—A Pilot Prospective StudyAmerican Journal of Therapeutics 2017; 24(2): e162 doi: 10.1097/MJT.0000000000000454
13
Daniel L. Ballantine, Stephanie J. Fisquet, James R. Winearls, John F. Fraser. Use of acid suppression medications in postoperative cardiac surgical intensive care unit patientsJournal of Pharmacy Practice and Research 2014; 44(3): 108 doi: 10.1002/jppr.1010
14
A. Komosa, J. M. Siller-Matula, J. Kowal, M. Lesiak, A. Siniawski, M. Mączyński, M. Michalak, T. Mularek-Kubzdela, S. Grajek. Comparison of the antiplatelet effect of two clopidogrel bisulfate formulations: Plavix and generic-EgitrombPlatelets 2015; 26(1): 43 doi: 10.3109/09537104.2013.877581
15
Nishank Jain, Robert F. Reilly. Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current Knowledge and Future DirectionsSeminars in Dialysis 2016; 29(5): 374 doi: 10.1111/sdi.12484
16
Timothy P. Shiraev, Andrew Bullen. Proton Pump Inhibitors and Cardiovascular Events: A Systematic ReviewHeart, Lung and Circulation 2018; 27(4): 443 doi: 10.1016/j.hlc.2017.10.020
17
Mohammed Jarrar, Shalini Behl, Ganiraju Manyam, Hany Ganah, Mohammed Nazir, Reem Nasab, Khaled Moustafa. Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapyMolecular Biology Reports 2016; 43(6): 473 doi: 10.1007/s11033-016-3983-1
18
Fanny Bonhomme, Pierre Fontana, Jean-Luc Reny. How to manage prasugrel and ticagrelor in daily practiceEuropean Journal of Internal Medicine 2014; 25(3): 213 doi: 10.1016/j.ejim.2014.01.016
19
Ann Marie Canelas, Randal O. Dull. A Case Approach to Perioperative Drug-Drug Interactions2015; : 681 doi: 10.1007/978-1-4614-7495-1_151
20
Prashanth Porayette, David Flockhart, Sandeep K. Gupta. One Size Fits One: Pharmacogenetics in GastroenterologyClinical Gastroenterology and Hepatology 2014; 12(4): 565 doi: 10.1016/j.cgh.2014.01.035
21
Young Ho Shin, Hyun Sik Gong, Goo Hyun Baek. Lower Trabecular Bone Score is Associated With the Use of Proton Pump InhibitorsJournal of Clinical Densitometry 2019; 22(2): 236 doi: 10.1016/j.jocd.2018.06.008
22
Shirley Siang Ning Tan, Keng Tat Koh, Lee Len Tiong, Tiong Kiam Ong, Alan Yean Yip Fong. Late Stent Thrombosis in a Patient With CYP2C19*3/*17 Genotype and Clopidogrel High On-Treatment Platelet Reactivity Pharmacogenomics 2018; 19(15): 1151 doi: 10.2217/pgs-2018-0082
23
Tarun Girotra, Forrest Lowe, Wuwei Feng, Bruce Ovbiagele. Antiplatelet Agents in Secondary Stroke Prevention: Selection, Timing, and DoseCurrent Treatment Options in Neurology 2018; 20(8) doi: 10.1007/s11940-018-0514-5
24
Brian A. Baldo, Nghia H. Pham. Drug Allergy2021; : 521 doi: 10.1007/978-3-030-51740-3_12
25
Danielle Duffy, Bridget Rooney, Suzanne Adams, David J Whellan. PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcersExpert Review of Cardiovascular Therapy 2014; 12(11): 1251 doi: 10.1586/14779072.2014.967214
26
James R. Butler, Tyrone Rogers, George Eckart, Gregory R. Martens, Eugene P. Ceppa, Michael G. House, Attila Nakeeb, C. Max Schmidt, Nicholas J. Zyromski. Is Antisecretory Therapy After Pancreatoduodenectomy Necessary? Meta-analysis and Contemporary Practices of Pancreatic SurgeonsJournal of Gastrointestinal Surgery 2015; 19(4): 604 doi: 10.1007/s11605-015-2765-8
27
Brian A. Baldo, Nghia H. Pham. Drug Allergy2013; : 419 doi: 10.1007/978-1-4614-7261-2_14
28
Tommy Andersson, Peter Nagy, Mohammad Niazi, Sven Nylander, Hal Galbraith, Santosh Ranjan, Lars Wallentin. Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy VolunteersAmerican Journal of Cardiovascular Drugs 2014; 14(3): 217 doi: 10.1007/s40256-014-0073-4
29
Martin Klieber, Herbert Oberacher, Silvia Hofstaetter, Beate Beer, Martin Neururer, Anton Amann, Hannes Alber, Anil Modak. CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized MedicineJournal of Pharmacology and Experimental Therapeutics 2015; 354(3): 426 doi: 10.1124/jpet.115.225680
30
Berit E.S. Jensen, Jane M. Hansen, Kasper S. Larsen, Anders B. Junker, Jens F. Lassen, Svend E. Jensen, Ove B. Schaffalitzky de Muckadell. Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapyEuropean Journal of Gastroenterology & Hepatology 2017; 29(10): 1118 doi: 10.1097/MEG.0000000000000934
31
Abdallah Damin Abukhalil, Tala Al Sheikh, Sandra Muallem, Ni'meh Al-Shami, Hani A Naseef. Prevalence and Safety of Prescribing PPIs with Clopidogrel in PalestinePatient Preference and Adherence 2023; : 749 doi: 10.2147/PPA.S404139
32
Andrew J. Gawron, Joseph Feinglass, John E. Pandolfino, Bruce K. Tan, Michiel J. Bove, Stephanie Shintani-Smith. Brand Name and Generic Proton Pump Inhibitor Prescriptions in the United States: Insights from the National Ambulatory Medical Care Survey (2006–2010)Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/689531
33
Kristy Yuan, Anthony S. Kim. When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet TherapyCurrent Treatment Options in Cardiovascular Medicine 2016; 18(4) doi: 10.1007/s11936-016-0449-7
34
Jelmer E. Oor, David J. Roks, Joris A. Broeders, Eric J. Hazebroek, Hein G. Gooszen. Seventeen-year Outcome of a Randomized Clinical Trial Comparing Laparoscopic and Conventional Nissen FundoplicationAnnals of Surgery 2017; 266(1): 23 doi: 10.1097/SLA.0000000000002106